Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L27 pseudogene 6 (RPL27P6)
- Target
- RPL27P6
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L27 pseudogene 6 (RPL27P6) is a non-coding genomic sequence in humans classified as a processed pseudogene related to the parent gene ribosomal protein L27 (RPL27)[4][8][11]. While its sequence closely resembles that of functional ribosomal protein genes, it does not encode a functional protein and is not involved in protein synthesis or any currently recognized biological process or disease pathway[2][6]. RPL27P6 has no current relevance as a drug target or biomarker. The naming convention follows the standard pseudogene nomenclature, with "P" designating pseudogenes derived from ribosomal protein parent genes. There is no evidence that RPL27P6 has any active biological or pathological role in humans[2][4][8][11].
- Other names
- RPL27_2_233RPL27P6
02
Mechanism of action
None known
03
Biological functions
None established (as a pseudogene, it has no known direct biological function; see context below)
04
Disease associations
None established (RPL27 itself can be involved in conditions like Diamond-Blackfan anemia, but RPL27P6 itself is not implicated in disease[4][8][11])
05
Safety considerations
None known
06
Interacting drugs
None known
07
Biomarkers
None known
Beyond the preview
Go deeper on Ribosomal protein L27 pseudogene 6 (RPL27P6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L27 pseudogene 6 (RPL27P6).